Summary A study involving the measurement of glutathione S-transferase activities and isoenzyme distributions in human ovarian tumours has been carried out. These tumours have been obtained either at initial debulking surgery, prior to cytotoxic chemotherapy, or at second look laparotomy following chemotherapy. The response rates of these two groups to chemotherapy differ markedly, wtih patients who have relapsed following initial chemotherapy showing a reduction in response rates to subsequent chemotherapy. Analysis of these data show no statistically significant differences between the glutathione S-transferase activity or isoenzyme distribution in these two groups of patients. Significant differences were observed in the glutathione-S-transferase activities (GST) between tumours and normal ovaries. GST activities in pre-chemotherapy tumours (n = 33, P = 0.01) and post-chemotherapy tumours (n = 20, P = 0. 001) where significantly higher than the GST activity in normal ovaries (n = 15). One feature was the expression of the basic isoenzyme which is expressed more in normal ovaries than in tumours. No differences in these parameters were observed in normal peritoneal tissue taken from patients before or after chemotherapy. These data do not support the hypothesis that changes in glutathione S-transferase enzyme activity or isoenzyme expression are major determinants of response to chemotherapy in ovarian tumours.
The use of platinum drugs has increased the response rates seen in patients with epithelial ovarian cancer (-70%, Gurney et al., 1990) . Modem combined drug therapy including a platinum containing agent can be expected to produce response rates of 60-80% (Ozols & Young, 1984) . Patients relapsing following therapy have a much lower response rate to the same or alternative chemotherapy with response rates in the order of 20% (Nash & Young, 1988; Zwelling, 1988) .
The mechanisms by which cells can become resistant to chemotherapy have been the subject of much investigation. The glutathione S-transferase enzymes, together with the ubiquitous tripeptide glutathione have been implicated in resistance to a number of drugs including the platinum drugs (Fujiwara et al., 1990) . These enzymes have also been used as markers for malignant and pre-malignant changes in a number of tissues .
This work describes the glutathione S-transferase activity and isoenzyme expression in ovarian tumours taken either before chemotherapy (at initial debulking surgery) or following combination chemotherapy (at second-look laparotomy). Similar measurements were performed on normal peritoneal and ovarian tissue collected at the time of oophorectomy for benign gynaecological conditions.
Materials and methods

Patients
Ovarian tumour specimens were provided by gynaecological surgeons throughout the North West of England. Samples were frozen in liquid nitrogen within minutes of excision and stored at -80°C until processing. Tumour 
Chemotherapy
The patients receiving chemotherapy prior to second-look laparotomy had received one of the following regimens:
Regimen A (n = 13) -carboplatin (300 mg m2) + cyclophosphamide (600 mg m2) alternating with ifosfamide (5 g m_2) and doxorubicin hydrochloride (50 mg m-2) at 4 week intervals for six cycles.
Regimen B (n = 1) -single agent cisplatinum (100 mg m2) once every 4 weeks for six cycles.
Regimen C (n = 4) -single agent carboplatin (400 mg m2) once every 4 weeks for six cycles.
Regimen D (n = 2) -melphalan (10 mg day') for 5 days, for six cycles at 5 week intervals.
Regimen E (n = 1) -Ifosfamide (5 g m-2) and doxorubicin hydrochloride (50 mg m-2) and 4 week intervals for six cycles. cosubstrates (Habig et al., 1974) . All enzyme activities were standardised for protein content. Briefly cell homogenates were incubated with CDNB.-(1 mM) in potassium phosphate buffer (0.1 M, pH 6.5, 37°C) and the increase in absorbance recorded at 350 nm on a Beckma'n DU8 spectrophotometer with kinetic accessory.
Immunohistochemistry
The glutathione S-transferase isoenzyme distribution was determined using three rabbit polyclonal antibodies raised against the human acidic (x), basic (a), and neutral (gs) forms of the enzymes (Randall et al., 1990) . Staining was performed on 4 y paraffin embedded sections previously prepared from the frozen tissue, following thawing in formalin (4%). Sections were dewaxed, alcohol fixed, air dried, and rehydrated in phosphate buffered saline (PBS). Endogenous peroxidase was blocked (30% H202, 0.3 g sodium azide in 3.3 ml PBS, for 10 min). Following incubation in swine serum (10%, 15 min), the primary antibodies were added (30 min, 25°C, 1:400 dilution in PBS), the sample washed twice in PBS and the second antibody added (Swine anti-rabbit peroxidase, Daks, 1/100 dilution, 30 min). The peroxidase reaction was developed using diaminobenzidine (0.5 mg ml-') and hydrogen peroxide (0.03%), followed by washing ( x 2, PBS) and counterstaining in Mayers haematoxylin.
Each sample was processed in duplicate substituting only the primary antibody for a control rabbit IgG, in order to eliminate the possibility of non-specific staining. Similarly at each staining session a sample of tissue known to express each isoenzyme was processed in an identical manner. This was used as a positive control of quality (anti i-kidney tubule, anti "-liver, and anti a-liver). Tables Ta and   Tb . Analysis of these' data reveals a significant difference in glutathione S-transferase isoenzyme expression between normal ovaries (n = 15), and tumours (n = 55) (Table II) . This change, (absent or reduced levels in tumour compared with normal ovary in the basic form of the enzyme) is highly significant (P<0.001, Fisher's Exact Test). However no difference was seen between the tumour specimens taken before chemotherapy (n = 33) and those taken after chemotherapy (n = 21) (P = 0.755, Fisher's Exact Test). No differences in GST activity or isoenzyme expression were seen in peritoneal tissue from the same groups of patients (n = 39). No differences were seen in expression of the neutral or acidic isoenzymes between the tumours and the normal ovarian tissue. Expression of the neutral isoenzyme is either low or absent in tumour, normal ovary, or peritoneum. Ovary (both normal and tumour) shows high expression of the acidic form (Figure la and b), whereas little is seen in peritoneal tissue. Staining of normal ovary for the basic isoform is shown in Figure Ic .
Scoring
The glutathione S-transferase (GST) activity in tumours, normal ovaries, and peritoneal tissue are shown in Table III . Analysis of these data (Kruskall-Wallis) showed significant differences in GST activity (P = 0.006) when normal ovaries, pre-chemotherapy tumour (1st look), and post-chemotherapy tumour (2nd look) were compared. Further analysis of the GST activity data (Mann-Whitney) showed that the differences occur between normal ovary (n = 15) and prechemotherapy tumour (n = 33, P = 0.011), and between normal ovary and post-chemotherapy tumour (n = 20, P = 0.001), but not between pre-and post-chemotherapy tumours (P = 0.630), tumour tissues having higher levels of GST activity than normal ovary.
Further analysis of these data showed that GST activity (Zwelling, 1988; Randall et al., 1990; Nakagawa et al., 1990; McGown & Fox, 1986) . However several other mechanisms of resistance have been suggested from in vitro work including altered metallothionein content, increased DNA repair, and reduced drug transport (Fujiwara et al., 1990 ). This work describes the glutathione S-transferase activity and isoenzyme distribution in a number of human ovarian tumour biopsies and normal ovaries. The tumour biopsies have been taken either before the commencement of cytotoxic chemotherapy or following the regimens described. A statistical analysis of these data showed no significant difference in glutathione S-transferase activity, or isoenzyme distribution between tumours which have or have not been exposed to cytotoxic chemotherapy. These, however, show markedly different responses to therapy. A significant difference in glutathione S-transferase activity and expression of the basic isoenzyme was found when tumours are compared to normal ovary. Both pre-and post-chemotherapy tumours have higher levels of GST activity than normal ovaries. Tumour tissue also showed reduced or undetectable expression of the basic GST isoenzyme. No significant differences were found in GST activity or expression between peritoneal tissue taken from patients with non-malignant disease (n = 8), patients with ovarian tumours who have not undergone chemotherapy (n = 15) and those who had (n = 8) (GST activity Kruskal-Wallis analysis, P = 0.41); isoenzyme distribution, see Table TI) . Tumours can be broadly categorised into those which show initial response to chemotherapy (intrinsic resistance) or those which, following an initial response, relapse and are refractory to further chemotherapy (acquired resistance). The biochemical processes which cause this decrease in response are complex. Studies to elucidate the mechanisms by which tumours can overcome the effects of cytotoxic agents have largely been carried out using cloned cell populations. These cell lines are generally selected by drug challenge, usually with a single agent, often express high levels of stable resistance. These studies have uncovered an impressive range of mechanisms which potentially unstable tumour cells can adopt to overcome cellular damage. It is likely that many novel mechanisms still await discovery.
However the clinical relevance of these mechanisms have yet to be fully elucidated. The development of resistance is a complex process and involves alterations in a number of cellular processes. It is difficult to know the precise contribu- 1  48  1  62  3  72  3  70  3  77  3  62  3  60  3  72  3  52  2  71  3  80  1  65  3  83  3  62  1  73  3  80  3  76  2  70  1  58  3  65  3  62  3  64  1  66  3  66  3  60  3  67  3  60  1  74  3  51  3  31  1  30  3  68  3  64  3  28  3  74  3 antibody to the acidic form of GST. This section was taken from a 28 year old patient with a stage III serous cystadenocarcinoma at first look surgery prior to chemotherapy. b Demonstrates a section from the same patient stained for endogenous peroxidase activity. c Demonstrates a normal ovary stained with the basic form of GST. (Misty et al., 1991) . Similarly no alterations in isoenzyme distribution between pre-and post-chemotherapy tumours was seen.
Secondly, as already discussed the GST activities represent average values for all cells within the tumour. Evidence for tumour heterogeneity was seen in the distribution of isoenzyme expression with a tumour. However adjacent biopsies from the same tumour or normal ovary showed no significant differences in GST activity. Therefore we have confidence that our measurement of GST in biopsies gives a measure of the average value within the tumour. In summary these data show that tumours show elevated of glutathione S-transferase activity when compared with normal ovaries. No significant difference was seen betwen tumours excised before or after chemotherapy. These data do not support the hypothesis that large changes in glutathione S-transferase activity are a major determinant of resistance to chemotherapy in ovarian tumours. The possibility still exists that sub-populations of resistant cells exist within the tumour. Similarly if chemotherapy induced only small changes a study of this type may have difficulty in identifying these in a tissue which shows a wide range of intrinsic GST activities. These questions will be better answered by a study using sequential biopsies obtained in the same patient before and after chemotherapy. This work was supported by the Cancer Research Campaign.
